{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:14:37Z","timestamp":1786356877433,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Innovation Plan of the Science and Technology Plan of Shenzhen","award":["JCYJ20170407131502032"],"award-info":[{"award-number":["JCYJ20170407131502032"]}]},{"name":"Sichuan Province Science and Technology Plan","award":["2019YFG0268"],"award-info":[{"award-number":["2019YFG0268"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.phrs.2020.104796","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:47:21Z","timestamp":1586346441000},"page":"104796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery"],"prefix":"10.1016","volume":"157","author":[{"given":"Jinhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.104796_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0010","article-title":"Rationally designed self-assembling nanoparticles to overcome mucus and epithelium transport barriers for oral vaccines against Helicobacter pylori","volume":"28","author":"Zhang","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.phrs.2020.104796_bib0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C8BM01454J","article-title":"A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA delivery","volume":"7","author":"Xie","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2020.104796_bib0020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nbt1204-1513","article-title":"Recombinant protein therapeutics\u2013success rates, market trends and values to 2010","volume":"22","author":"Pavlouand","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2020.104796_bib0025","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Wei","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2020.104796_bib0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/ar200234q","article-title":"pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications","volume":"45","author":"Hsing-Wen","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.phrs.2020.104796_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","article-title":"The big picture on nanomedicine: the state of investigational and approved nanomedicine products","volume":"9","author":"Etheridge","year":"2013","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.phrs.2020.104796_bib0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquistand","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0045","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/acs.nanolett.8b02229","article-title":"Nanoparticles targeted against cryptococcal pneumonia by interactions between chitosan and its peptide ligand","volume":"18","author":"Tang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2020.104796_bib0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.104796_bib0055","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1016\/j.biomaterials.2011.05.079","article-title":"Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles","volume":"32","author":"Swarnakar","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2020.104796_bib0060","doi-asserted-by":"crossref","first-page":"014","DOI":"10.17352\/2455-3492.000026","article-title":"Preparation of nanocellulose and its potential application","volume":"4","author":"Jasmaniaand","year":"2018","journal-title":"Int. J. Nanomater. Nanotechnol. Nanomed."},{"key":"10.1016\/j.phrs.2020.104796_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","article-title":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","volume":"233","author":"Sheng","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.104796_bib0070","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/acs.biomac.9b00040","article-title":"Click nucleic acid mediated loading of prodrug activating enzymes in PEG-PLGA nanoparticles for combination chemotherapy","volume":"20","author":"Harguindey","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2020.104796_bib0075","article-title":"Semi-elastic core-shell nanoparticles enhanced the oral bioavailability of peptide drugs","author":"Zhao","year":"2019","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.phrs.2020.104796_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2020.104796_bib0085","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.biomaterials.2013.01.030","article-title":"Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids","volume":"34","author":"Mo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2020.104796_bib0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2012.06.040","article-title":"An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery","volume":"436","author":"Li","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2020.104796_bib0095","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/acsami.5b11619","article-title":"An MMP-2 responsive liposome integrating antifibrosis and chemotherapeutic drugs for enhanced drug perfusion and efficacy in pancreatic cancer","volume":"8","author":"Ji","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2020.104796_bib0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C4BM00427B","article-title":"Lipid-coated polymeric nanoparticles for cancer drug delivery","volume":"3","author":"Krishnamurthy","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2020.104796_bib0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fphar.2019.00102","article-title":"Lipid nanoparticles-encapsulated YF4: a potential therapeutic oral peptide delivery system for hypertension treatment","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104796_bib0110","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/s41467-018-05061-3","article-title":"Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2020.104796_bib0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.addr.2013.01.002","article-title":"Targeted nanoparticles with novel non-peptidic ligands for oral delivery","volume":"65","author":"des Rieux","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.apsb.2019.01.004","article-title":"Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides\/proteins","volume":"9","author":"Han","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2020.104796_bib0125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakatand","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/bm300316n","article-title":"Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles","volume":"13","author":"Sunoqrot","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2020.104796_bib0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/mp500499x","article-title":"Targeted decationized polyplexes for siRNA delivery","volume":"12","author":"Novo","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2020.104796_bib0140","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1016\/j.biomaterials.2011.07.067","article-title":"Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis","volume":"32","author":"Werner","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2020.104796_bib0145","first-page":"40","article-title":"Folate-targeted nanostructured chitosan\/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells","volume":"14","author":"Soe","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2020.104796_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.addr.2019.06.008","article-title":"Absorption, distribution, metabolism and excretion of the biomaterials used in nanocarrier drug delivery systems","volume":"143","author":"Su","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0155","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/ijms17121977","article-title":"Enhanced and extended anti-hypertensive effect of VP5 nanoparticles","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104796_bib0160","doi-asserted-by":"crossref","first-page":"25753","DOI":"10.1021\/acsami.6b08603","article-title":"Combined tumor- and neovascular-\u201cdual targeting\u201d gene\/chemo-therapy suppresses tumor growth and angiogenesis","volume":"8","author":"Xu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2020.104796_bib0165","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/nn4058215","article-title":"Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer\u2019s disease by accelerating the clearance of amyloid-beta","volume":"8","author":"Qingxiang","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2020.104796_bib0170","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/adma.201404788","article-title":"Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake","volume":"27","author":"Sun","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2020.104796_bib0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","article-title":"Core\u2013shell-type lipid\u2013polymer hybrid nanoparticles as a drug delivery platform","volume":"9","author":"Mandal","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.phrs.2020.104796_bib0180","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/bm700753q","article-title":"Steric stabilization of lipid\/polymer particle assemblies by poly(ethylene glycol)-lipids","volume":"8","author":"Julie","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2020.104796_bib0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2007.11.002","article-title":"Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery","volume":"354","author":"Tahara","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2020.104796_bib0190","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Liangfang","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2020.104796_bib0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0200","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/S0021-9258(17)41848-5","article-title":"Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis","volume":"269","author":"Leeand","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104796_bib0205","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1021\/acsnano.5b01326","article-title":"Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake","volume":"9","author":"Pelaz","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2020.104796_bib0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.104796_bib0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2020.104796_bib0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40005-015-0221-0","article-title":"Cellular uptake of poly(dl-lactide-co-glycolide) nanoparticles: effects of drugs and surface characteristics of nanoparticles","volume":"45","author":"Lee","year":"2015","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.phrs.2020.104796_bib0225","first-page":"798","article-title":"The pathway of absorption and conveying of puerarin microemulsion-in-oil","volume":"44","author":"Lei","year":"2009","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2020.104796_bib0230","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1021\/jf703640p","article-title":"Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers","volume":"56","author":"Lin","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2020.104796_bib0235","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biomaterials.2013.10.020","article-title":"Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas","volume":"35","author":"Peifeng","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2020.104796_bib0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-009-0047-4","article-title":"Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3\/Abcc3) facilitates intestinal absorption of folates in mouse","volume":"27","author":"Kitamura","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2020.104796_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2020.104796_bib0250","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11095-014-1578-x","article-title":"Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies","volume":"32","author":"Lawless","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2020.104796_bib0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","article-title":"Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery","volume":"151","author":"Fan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2020.104796_bib0260","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1016\/j.biomaterials.2010.05.009","article-title":"Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection","volume":"31","author":"Lipka","year":"2010","journal-title":"Biomaterials"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182031104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182031104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:08:18Z","timestamp":1760911698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182031104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":52,"alternative-id":["S104366182031104X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104796","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104796"}}